BeOne Medicines
ONC
#533
Rank
NZ$81.50 B
Marketcap
NZ$713.50
Share price
-2.19%
Change (1 day)
13.23%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeOne Medicines Sustainability Report 2025

Sustainability Report 2025

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2024

Sustainability Report 2024

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report